5366
W. Sun et al. / Tetrahedron 68 (2012) 5363e5367
prepared in 0.1 M phosphate buffer at pH 7.4 (0.1% DMSO). Sub-
sequently, the solutions were transferred into a 1 cm quartz cell and
UV absorbance data were recorded immediately. The fluorescence
excitation wavelengths used herein were the UV lmax values.
Human ovarian clear cell carcinoma cell (ES-2) was grown in
RPMI-1640 media with 5% CO2 and 95% air at 37 ꢃC. Cells were then
transferred on 24-well plate and allowed to adhere for 12 h. After
the culture medium was removed, the cells were carefully washed
with PBS (phosphate buffered saline), and then incubated with
bis(pinacolato)diboron (0.52 g, 2.34 mmol), Pd(dppf)Cl2 (34 mg,
0.08 mmol) and potassium acetate (0.46 g, 4.68 mmol) in dioxane
(15 mL) was stirred at 90 ꢃC overnight under nitrogen atmosphere.
After cooled to room temperature, the reaction mixture was diluted
with CH2Cl2, washed with H2O and brine, and dried over Na2SO4.
After removal of solvent, the reaction mixture was purified by flash
chromatography on silica gel (PE/methylene chloride¼2/1) to af-
ford 3b as a white powder, yield 69.2%, mp 202e204 ꢃC, 1H NMR
(300 MHz, CDCl3):
d
1.419 (s, 12H), 3.637 (m, 2H), 4.160 (t, J¼6.6 Hz,
probe 1a or 1b (20
mM, 10
mM and 5
m
M; 0.5:100 DMSO/PBS, v/v, pH
2H), 4.798 (s, 1H), 7.921 (t, J¼7.8 Hz, 1H), 8.242 (d, J¼7.2 Hz, 1H),
8.497 (m, 2H), 9.017 (d, J¼8.4 Hz, 1H); HRMS m/z calcd for
C20H23BNO5 [(MþH)þ] 368.1665; found 368.1670.
7.4) at 37 ꢃC for 20 min. Fluorescence imaging was performed after
washing the cells three times with PBS buffer. The fluorescence
images were taken in optical windows between 540 and 580 nm
(green) using an OLMPUS CK30-F200 fluorescent microscope. The
images for the corresponding N-methylmaleimide controls were
taken with identical settings.
4.3.3. 6-Hydroxy-2-(2-hydroxyethyl)-1H-benzo[de]isoquinoline-
1,3(2H)-dione (4b). To a solution of 3b (150 mg, 0.41 mmol) in 3 mL
DMF, 3 mL H2O2 (30%) was added, and the mixture was then stirred
at room temperature for 2 h, diluted with ethyl acetate, extracted
with 1 M HCl and brine, and dried over MgSO4. After solvent re-
moval, the crude product was purified by flash chromatography
(methylene chloride/methanol¼70:1) on silica gel to give 53 mg
4.2. Preparation of probe 1a
4.2.1. N-Ethyl-4-bromo-1,8-naphthalimide (2a). Compound 2a was
synthesized according to literature procedures.7
yellow product 4b, yield 51.9%, 1H NMR (300 MHz, DMSO):
d 3.598
(m, 2H), 4.132 (t, J¼6.6 Hz, 2H), 4.806 (t, J¼5.4 Hz, 1H), 7.160 (d,
J¼8.4 Hz, 1H), 7.770 (t, J¼7.8 Hz, 1H), 8.362 (d, J¼7.8 Hz, 1H), 8.479
(d, J¼7.8 Hz, 1H), 8.539 (d, J¼8.4 Hz, 1H), 11.867 (s, 1H).
4.2.2. 2-Ethyl-6-hydroxy-1H-benzo[de]isoquinoline-1,3(2H)-dione
(4a).8 A mixture of compound 2a (0.65 g, 2.14 mmol), CH3ONa
(0.92 g, 17 mmol) and CuSO4$5H2O (64 mg, 0.25 mmol) were
refluxed in 10 mL CH3OH for 12 h. Subsequently, 20 mL cold water
was added in the above mixture to give a yellow precipitate. After
filtration, compound 3a was obtained in 91% yield. A mixture of
compound 3a (0.15 g, 0.59 mmol) and 5 mL HI (57%) was refluxed
by 6 h. After cooling and filtration, compound 4a was obtained as
4.3.4. 2-(2-Hydroxyethyl)-1,3-dioxo-2,3-dihydro-1H-benzo[de]iso-
quinolin-6-yl 2,4-dinitrobenzenesulfonate (1b). The synthesis is
analogous to 1a with compound 4b as the starting material. The
product was obtained as a yellow solid in 72.9% yield, mp
201e203 ꢃC. 1H NMR (300 MHz, DMSO):
d 3.621 (d, 2H), 4.148 (t,
a yellow needle in 83% yield. 1H NMR (300 MHz, DMSO):
d
1.182 (t,
J¼6.3 Hz, 2H), 4.792 (t, J¼6.0 Hz, 1H), 7.674 (d, J¼8.4 Hz, 1H), 7.958
(t, J¼7.8 Hz, 1H), 8.380 (m, 2H), 8.477 (d, J¼8.4 Hz, 1H), 8.572 (d,
J¼7.5 Hz, 1H), 8.625 (dd, J1¼2.4 Hz, J2¼8.7 Hz, 1H), 9.162 (d,
J¼6.6 Hz, 3H), 4.064 (m, 2H), 7.166 (d, J¼8.4 Hz, 1H), 7.776 (t,
J¼7.2 Hz, 1H), 8.373 (d, J¼8.4 Hz, 1H), 8.491 (d, J¼7.2 Hz, 1H), 8.545
(d, J¼7.2 Hz, 1H), 11.883 (s, 1H).
J¼2.1 Hz, 1H); 13C NMR (DMSO, 75 MHz):
d 163.11, 162.50, 151.71,
148.31, 148.07, 133.74, 131.59, 131.05, 130.62, 128.84, 128.69, 127.77,
127.21, 124.71, 122.69, 122.13, 121.32, 119.97, 57.69, 41.97; IR (KBr,
cmꢂ1): 3514, 3103,1702, 1659, 1557, 1543, 1383, 1350, 1232, 1191,
4.2.3. 2-Ethyl-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-6-yl
2,4-dinitrobenzenesulfonate (1a). To a suspension of 4a (0.10 g,
0.41 mmol) in 5 mL dichloromethane, Et3N (71
m
L, 0.51 mmol) was
1069, 82,946, 795, 785, 755, 731; HRMS m/z calcd for C20H13N3O10
S
added dropwise at 0 ꢃC. The mixture was stirred for 5 min, and
treated with 2,4-dinitrobenzenesulfonyl chloride (0.13 g,
0.49 mmol). The resulting mixture was stirred at room temperature
for 4 h, diluted with CH2Cl2 (20 mL), washed with 1 M HCl (20 mL)
and brine (20 mL), and dried over MgSO4. After solvent removal, the
crude product was purified by flash chromatography (methylene
chloride) on silica gel to give 0.15 g yellow product 1a (76.9%), mp
[(MþH)þ] 488.0394; found 488.0389.
Acknowledgements
We acknowledge Professor Xiaodong Shi (Department of
Chemistry, West Virginia University, USA) for his assistance in
manuscript writing. The present work was supported by grants
from Shandong Natural Science Foundation (No. JQ201019) and
Independent Innovation Foundation of Shandong University,
IIFSDU (No. 2010JQ005).
200e202 ꢃC. 1H NMR (300 MHz, DMSO):
d
1.210 (t, J¼7.2 Hz, 3H),
4.078 (m, 2H), 7.678 (d, J¼8.1 Hz, 1H), 7.956 (m, 1H), 8.381 (m, 2H),
8.486 (d, J¼8.1 Hz, 1H), 8.607 (m, 2H), 9.161 (d, J¼2.4 Hz, 1H); 13C
NMR (DMSO, 75 MHz):
d 162.78, 162.17, 151.71, 148.37, 148.07,
133.76, 131.61, 131.09, 130.58, 128.80, 128.70, 127.76, 127.28, 124.74,
122.63, 122.06, 121.31, 120.00, 34.90, 12.96; IR (KBr, cmꢂ1): 3108,
1701, 1663, 1556, 1541, 1386, 1349, 1246, 1191, 1072, 846, 796, 783,
753, 731; HRMS m/z calcd for C20H13N3O9S [(MþH)þ] 472.0445;
found 472.0449.
Supplementary data
Spectroscopic data related to this article can be found online at
InChiKeys of the most important compounds described in this
article.
4.3. Preparation of probe 1b
References and notes
4.3.1. 6-Bromo-2-(2-hydroxyethyl)-1H-benzo[de]isoquinoline-
1,3(2H)-dione (2b). The synthesis is analogous to 2a with etha-
nolamine as the starting material. The product was obtained as
1. (a) Shahrokhian, S. Anal. Chem. 2001, 73, 5972e5978; (b) Townsend, D. M.; Tew,
K. D.; Tapiero, H. Biomed. Pharmacother. 2003, 57, 145e155; (c) Njalsson, R.;
Norgren, S. Acta Paediatr. 2005, 94, 132e137.
2. (a) Amrolia, P.; Sullivan, S. G.; Stern, A.; Munday, R. J. Appl. Toxicol. 1989, 9,
113e118; (b) Munday, R. J. Appl. Toxicol. 1985, 5, 402e408; (c) Fairchild, E. J.;
Stokinger, H. E. Am. Ind. Hyg. Assoc. J. 1958, 19, 171e189.
3. (a) Xu, Z.; Chen, X.; Kim, H. N.; Yoon, J. Chem. Soc. Rev. 2010, 39, 127e137; (b)
Cho, D. G.; Sessler, J. L. Chem. Soc. Rev. 2009, 38, 1647e1662; (c) Blom, H.;
Kastrup, L.; Eggeling, C. Curr. Pharm. Biotechnol. 2006, 7, 51e66; (d) Kim, S. A.;
Schwille, P. Curr. Opin. Neurobiol. 2003, 13, 583e590; (e) de Silva, A. P.;
ꢀ
a yellow solid, yield 92%, 1H NMR (300 MHz, DMSO):
d 3.629 (t,
J¼6.6 Hz, 2H), 4.145 (t, J¼6.6 Hz, 2H), 4.816 (s, 1H), 8.004 (m, 1H),
8.226 (d, J¼7.8 Hz, 1H), 8.338 (d, J¼7.8 Hz, 1H), 8.563 (m, 3H).
4.3.2. N-Ethanol-4-(4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1,8-
naphthalimide (3b). A mixture of compound 2b (0.50 g, 1.56 mmol),